Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 18-May-2013
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 22)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
20-May-13 Alpha Street Research Hunter Orr OGXI - OncoGenex Pharmaceuticals Inc - Rated a Hold - Company Analysis and ASR Ranking Report 9 $24 View Abstract
17-May-13 New Constructs, LLC N/A OGXI: Due Diligence Review: Forensic Earnings and Valuation 13 $25 View Abstract
17-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-drugs 18 $207 View Abstract
17-May-13 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ONCOGENEX PHARMACEUTICALS including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
16-May-13 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for OGXI 11 $126.50 View Abstract
13-May-13 Pechala's Reports Lubomir Pechala ONCOGENEX PHARMACEUTICALS INC (OGXI) - REPORT FOR ACTIVE TRADERS 1 $25 View Abstract
13-May-13 Wright Reports N/A Wright Investors Service Comprehensive Report for Oncogenex Pharmaceuticals, Incorporation 38 $437 View Abstract
11-May-13 S&P Capital IQ Quantitative Report N/A OncoGenex Pharmaceuticals 5 $57.50 View Abstract
11-May-13 Pechala's Reports Frantisek Pechala ONCOGENEX PHARMACEUTICALS INC (OGXI) 12-months forecast 1 $15 View Abstract
10-May-13 Zacks Investment Research Inc. N/A ONCOGENEX PHARM (OGXI) Zacks Company Snapshot 1 $11.50 View Abstract
Next 12

Independent Reports (Showing 1 to 10 of 22)

Release
Date Contributor Author Title Pages Price More Info
20-May-13 Alpha Street Research Hunter Orr OGXI - OncoGenex Pharmaceuticals Inc - Rated a Hold - Company Analysis and ASR Ranking Report 9 $24 View Abstract
17-May-13 New Constructs, LLC N/A OGXI: Due Diligence Review: Forensic Earnings and Valuation 13 $25 View Abstract
17-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-drugs 18 $207 View Abstract
17-May-13 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ONCOGENEX PHARMACEUTICALS including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
16-May-13 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for OGXI 11 $126.50 View Abstract
13-May-13 Pechala's Reports Lubomir Pechala ONCOGENEX PHARMACEUTICALS INC (OGXI) - REPORT FOR ACTIVE TRADERS 1 $25 View Abstract
13-May-13 Wright Reports N/A Wright Investors Service Comprehensive Report for Oncogenex Pharmaceuticals, Incorporation 38 $437 View Abstract
11-May-13 S&P Capital IQ Quantitative Report N/A OncoGenex Pharmaceuticals 5 $57.50 View Abstract
11-May-13 Pechala's Reports Frantisek Pechala ONCOGENEX PHARMACEUTICALS INC (OGXI) 12-months forecast 1 $15 View Abstract
10-May-13 Zacks Investment Research Inc. N/A ONCOGENEX PHARM (OGXI) Zacks Company Snapshot 1 $11.50 View Abstract
Next 12

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.